First round % (n) | Second round % (n) | Third round % (n) | |
Cancers | |||
Total | 0.21 (167415) | 0.12 (164077) | 0.07 (175853) |
Males | 0.31 (75724) | 0.16 (74686) | 0.10 (80624) |
Females | 0.13 (91691) | 0.08 (89391) | 0.05 (95229) |
Polyp cancer | 0.04 (167415) | 0.02 (164077) | 0.01 (175853) |
Adenomas | |||
Total | 0.65 (167415) | 0.52 (164077) | 0.28 (175853) |
High-risk adenoma | 0.08 (167415) | 0.05 (164077) | 0.03 (175853) |
Polyp cancers are included in the total cancer figures and given separately.
The decline in cancer detection rate round on round was statistically significant at the p<0.001 level, and the difference between males and females was statistically significant at the p<0.001 level in all rounds (χ2 test).